The Outcome of Patients With Cystic Biliary Atresia With Intact Proximal Hepatic Ducts Following Hepatic-Cyst-Jejunostomy.
Asai, A; Wu, JF; Wang, KS; Yamataka, A; Nio, M; Su, DJ; Short, C; Tsuboi, K; Ochi, T; Sasaki, H; et al.
Journal of Pediatric Gastroenterology and Nutrition.
2022;
75:131-137.
In vivo partial cellular reprogramming enhances liver plasticity and regeneration.
Hishida, T; Yamamoto, M; Hishida-Nozaki, Y; Shao, C; Huang, L; Wang, C; Shojima, K; Xue, Y; Hang, Y; Shokhirev, M; et al.
Cell Reports.
2022;
39.
Human iPSC-derived hepatocyte system models cholestasis with tight junction protein 2 deficiency.
Li, CZ; Ogawa, H; Ng, SS; Chen, X; Kishimoto, E; Sakabe, K; Fukami, A; Hu, YC; Mayhew, CN; Hellmann, J; et al.
2022;
4.
Acute liver dysfunction with delayed peak of serum aminotransferase levels as a presentation of ornithine transcarbamylase deficiency in females.
Clarkston, K; Lee, J; Donoghue, S; Peters, H; Eiroa, H; Shah, AA; Loomes, K; Wen, J; Oliver, M; Hardikar, W; et al.
American Journal of Medical Genetics, Part A.
2021;
185:909-915.
Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation.
Hayashi, H; Osaka, S; Sakabe, K; Fukami, A; Kishimoto, E; Aihara, E; Sabu, Y; Mizutani, A; Kusuhara, H; Naritaka, N; et al.
Stem Cell Reports.
2021;
16:309-323.
High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
Shinozawa, T; Kimura, M; Cai, Y; Saiki, N; Yoneyama, Y; Ouchi, R; Koike, H; Maezawa, M; Zhang, RR; Dunn, A; et al.
Gastroenterology.
2021;
160:831-846.e10.
Organoid Medicine in Hepatology.
Sakabe, K; Takebe, T; Asai, A.
Clinical Liver Disease.
2020;
15:3-8.
Prospective Assessment of Ultrasound Shear Wave Elastography for Discriminating Biliary Atresia from other Causes of Neonatal Cholestasis.
Dillman, JR; DiPaola, FW; Smith, SJ; Barth, RA; Asai, A; Lam, S; Campbell, KM; Bezerra, JA; Tiao, GM; Trout, AT.
Journal of Pediatrics.
2019;
212:60-65.e3.